Nachrichten
Mehr Nachrichten
-
-
-
15.06.2022
Investment Outlook 2022 – mid-year update
The investment landscape has changed substantially in the last six months: conflict has broken out in Ukraine, leading to various geopolitical and social ramifications, and inflationary pressure has been rising and remains a concern across many regions.
-
24.05.2022
«Ich bin nicht sehr optimistisch für eine weiche Landung»
Finews (19.05.2022) - Die Normalität der vergangenen Jahre werde an den Finanzmärkten erstmal nicht mehr zurückkehren, sagt Norman Villamin, CIO Wealth Management, zu finews.ch.
-
26.04.2022
“The main aim is to avoid any accidents related to rising interest rates”
Le Temps (20.04.2022) - The war in Ukraine has created a highly unusual environment for investors, writes Michaël Lok, Group Chief Investment Officer at UBP.
-
19.01.2022
«Das Fed wird Anleihen schneller verkaufen als 2017»
Finanz und Wirtschaft (17.01.2022) - Norman Villamin, Anlagechef Wealth Management von Union Bancaire Privée, erwartet einen radikalen Kurswechsel in der Geldpolitik. Aktien dürften das besser meistern als Anleihen.
-
22.11.2021
CRISPR: the implications of gene editing
In the latest episode of UBP’s Expert series, Norman Villamin, CIO Wealth Management and Pierre Corby, Equity Analyst Healthcare, invited Dr Samarth Kulkarni, CEO of CRISPR Therapeutics, to discuss the challenges and investment opportunities offered by medical innovation, specifically in the field of gene editing.
-
-
11.06.2021
Transitioning to a Brave New World
Volatility is back in Chinese equity markets: after rallying 90% from its trough in March 2020 to a peak in February 2021, MSCI China has fallen by 16% over the past month.
-
12.05.2021
«Das Fed lässt keinen zu starken Zinsanstieg zu»
Finanz und Wirtschaft (19.01.2021) - Norman Villamin, CIO Wealth Management von Union Bancaire Privée, hält die Furcht vor deutlich höheren Zinsen für verfrüht. Er zieht Bergbautitel den Bankaktien vor.
-
06.05.2021
Why the Japanese market is performing well again
Japan’s equity markets have outpaced other major developed market equities in both 2020 and year-to-date in 2021 as the world seeks to transition to a post-pandemic recovery.
-
14.04.2021
The vaccine disrupting the pharma industry
UBP talks to Stéphane Bancel, Moderna CEO, to learn how the mRNA technology not only made one of the first COVID-19 vaccines possible, but, more importantly for investors, has the potential to disrupt the broader pharmaceutical industry in its wake.
Our latest podcasts
-
Europe: rewriting its future
Redner: Norman Villamin, Patrice Gautry, Peter Kinsella
-
DeepSeek: Chinese challenger enters the AI race
Redner: Dimitri Kallianiotis
Our latest podcasts
-
From peak to peak with patience and passion
-
Finnish ex-premier addresses UBP clients
Redner: Adrian Künzi